Literature DB >> 2499182

The diagnosis of neurofibromatosis-1 in the child under the age of 6 years.

A C Obringer1, A T Meadows, E H Zackai.   

Abstract

One-hundred sixty children under the age of 6 years presented for diagnostic evaluation regarding neurofibromatosis-1 (NF-1). Using the National Institutes of Health Consensus Conference criteria, 151 (94%) of the children were classified on initial examination: 112 were diagnosed as having NF-1 and 39 were found to be unaffected (all 39 have remained asymptomatic on follow-up). Nine could not be classified (3 have subsequently met minimal diagnostic criteria on follow-up). Clinical manifestations of NF-1 include cafe au lait spots (97%), freckling in the axillary or inguinal region (81%), Lisch nodules (30%), neurofibromas (15%), pseudoarthrosis (6%), and optic nerve gliomas (4%). More than minimal diagnostic criteria were met by 80% of the children who had a positive family history and by 32% of those who did not. Thus, the clinical diagnosis of NF-1 is possible in the child who is under 6 years of age, and the National Institutes of Health criteria are useful and applicable.

Entities:  

Mesh:

Year:  1989        PMID: 2499182     DOI: 10.1001/archpedi.1989.02150180099028

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  12 in total

1.  Von recklinghausens disease: a series of four cases with variable expression.

Authors:  K P Arun; P Thomas Joseph; H P Jaishankar; M S Abhinethra
Journal:  J Maxillofac Oral Surg       Date:  2013-02-07

2.  Neurofibromatosis type 1 in children.

Authors:  G R Beauchamp
Journal:  Trans Am Ophthalmol Soc       Date:  1995

3.  Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital.

Authors:  M H Cnossen; K G Moons; M P Garssen; N M Pasmans; A de Goede-Bolder; M F Niermeijer; D E Grobbee
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

Review 4.  Neurofibromatosis type 1.

Authors:  Kevin P Boyd; Bruce R Korf; Amy Theos
Journal:  J Am Acad Dermatol       Date:  2009-07       Impact factor: 11.527

5.  Central nervous system imaging in reevaluation of patients with neurofibromatosis type 1.

Authors:  P Balestri; L Calistri; R Vivarelli; G Bartalini; L Mancini; A Berardi; A Fois
Journal:  Childs Nerv Syst       Date:  1993-12       Impact factor: 1.475

6.  A prospective 10 year follow up study of patients with neurofibromatosis type 1.

Authors:  M H Cnossen; A de Goede-Bolder; K M van den Broek; C M Waasdorp; A P Oranje; H Stroink; H J Simonsz; A M van den Ouweland; D J Halley; M F Niermeijer
Journal:  Arch Dis Child       Date:  1998-05       Impact factor: 3.791

7.  Neurocutaneous syndrome: a prospective study.

Authors:  Radheshyam Purkait; Tryambak Samanta; Sachin Thakur; Sandipan Dhar
Journal:  Indian J Dermatol       Date:  2011-07       Impact factor: 1.494

8.  Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study.

Authors:  Zlatko Sabol; Biserka Resić; Romana Gjergja Juraski; Filip Sabol; Matilda Kovac Sizgorić; Kresimir Orsolić; David Ozretić; Dubravka Sepić-Grahovac
Journal:  Croat Med J       Date:  2011-08-15       Impact factor: 1.351

9.  Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

Authors:  Christina Bergqvist; Amandine Servy; Laurence Valeyrie-Allanore; Salah Ferkal; Patrick Combemale; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

10.  The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial.

Authors:  Laurence Lion-François; François Gueyffier; Catherine Mercier; Daniel Gérard; Vania Herbillon; Isabelle Kemlin; Diana Rodriguez; Tiphanie Ginhoux; Emeline Peyric; Virginie Coutinho; Valentine Bréant; Vincent des Portes; Stéphane Pinson; Patrick Combemale; Behrouz Kassaï
Journal:  Orphanet J Rare Dis       Date:  2014-09-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.